Parameter | % traced (95% CI#) | Adjusted OR (95% CI) | P |
---|---|---|---|
Gender | Â | Â | 0.34 |
   Female | 73.8 (68.9-78.3) | 1.20 (0.83-1.73) |  |
   Male | 73.7 (68.4-78.5) | 1 |  |
Age group | Â | Â | 0.11 |
   15-29 | 63.9 (54.7-72.4) | 1 |  |
   30-39 | 74.2 (68.7-79.2) | 1.59 (0.99-2.55) |  |
   40-49 | 78.5 (72.0-84.1) | 1.91 (1.12-3.24) |  |
   ≥ 50 | 76.2 (63.8-86.0) | 1.71 (0.83-3.5) |  |
Reason start ART | Â | Â | 0.39 |
   Low CD4 count | 72.2 (60.4-82.1) | 1 |  |
   WHO stage 3 | 73.9 (69.5-77.9) | 1.15 (0.64-2.04) |  |
   WHO stage 4 | 71.8 (63.0-79.5) | 1.07 (0.54-2.12) |  |
   Other/unknown | 89.5 (66.9-98.7) | 3.38 (0.7-16.43) |  |
Time of last visit* | Â | Â | 0.94 |
   No follow-up | 72.5 (63.1-80.6) | 1 |  |
   Months 1 to 6 | 71.3 (66.1-76.1) | 0.95 (0.57-1.57) |  |
   Months 7 to 12 | 76.9 (66.0-85.7) | 0.92 (0.45-1.89) |  |
   Months 13 or later | 78.7 (71.0-85.2) | 0.77 (0.34-1.74) |  |
Telephone contact | Â | Â | < 0.001 |
   None | 67.0 (61.9-71.9) | 1 |  |
   Available | 81.4 (76.6-85.6) | 2.07 (1.42-3.01) |  |
Treatment period | Â | Â | 0.13 |
   Paying | 79.5 (73.5-84.6) | 1.66 (0.85-3.23) |  |
   Free ART | 70.9 (66.4-75.1) | 1 |  |